Optimal treatment for chronic conditions by innovative, patented, clinically proven oral cannabinoid products.
Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Elixie is an Israeli biotech company established in 2019 by experienced entrepreneurs to invent, develop, invest, and commercialize Med-Tech technologies to improve the health and well-being of people suffering from chronic indications. We aim to unlock traditional plant medicines' enormous potential by utilizing novel drug delivery technologies to create advanced combination products that connect traditional wisdom with updated scientific tools and techniques.
Elixie has headquarters in Tel Aviv, an R&D lab in Casarea, and strategic relations with the Hebrew University of Jerusalem. Our lab collaborates with pre-clinical and clinical sites to provide cutting-edge scientific research that helps generate genuinely innovative products. We believe in collaborations and partnerships and invite research institutes, entrepreneurs, activists, governments, industry, and business entities to participate in our mission, progressing human health and quality of life.